The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 3 , Pages 619-623 , September 2007

Sarcomatoid lung cancer (spindle/giant cells): An aggressive disease?

  • Nicolas Venissac, MD

      Affiliations

    • Department of Thoracic Surgery, Pasteur Hospital, Nice, France
    • ,
  • Daniel Pop, MD

      Affiliations

    • Department of Thoracic Surgery, Pasteur Hospital, Nice, France
    • Corresponding Author InformationAddress for reprints: Daniel Pop, MD, Thoracic Surgery Department, Pasteur Hospital–Building H1, 30 Avenue de la Voie Romaine, 06002 Nice, France.
    • ,
  • Sandra Lassalle, MD

      Affiliations

    • Department of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France
    • ,
  • Frederic Berthier, MD

      Affiliations

    • Department of Medical Informatics and Information, Cimiez Hospital, Nice, France.
    • ,
  • Paul Hofman, MD, PhD

      Affiliations

    • Department of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France
    • ,
  • Jérôme Mouroux, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Pasteur Hospital, Nice, France

Received 27 January 2007 ,Revised 7 May 2007 ,Accepted 11 May 2007.

References 

  1. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003;51:3–30
  2. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, et al. EUROCARE Working Group EUROCARE-3: survival of cancer patients diagnosed 1990-94—results and commentary. Ann Oncol. 2003;14(suppl 5):v61–v118
  3. In:  Sobin LH editors. Histological typing of lung tumors. 2nd ed.. Geneva: World Health Organization; 1981;
  4. In:  Travis WD editors. Histological typing of lung tumors and pleural tumors. 3rd ed.. Geneva: World Health Organization; 1999;
  5. Travis WD. World Health Organization classification of tumors. In: Pathology and genetics of tumors of the lung, pleura, thymus and heart. 4th ed.. Geneva: World Health Organization; 2004;
  6. Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid or sarcomatous elements: a clinicopathologic and immunohistochemical study in 75 cases. Am J Surg Pathol. 2003;27:311–324
  7. Pelosi G, Fraggetta F, Nappi O, Pastorino U, Maisonneuve P, Pasini F, et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility. Am J Surg Pathol. 2003;27:1203–1215
  8. Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer. 1999;86:608–616
  9. Attanoos RL, Papagiannis A, Suttinart P, Goddard H, Papotti M, Gibbs AR. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?. Histopathology. 1998;32:225–231
  10. Wick MR, Ritter JH, Humphrey PA. Sarcomatoid carcinomas of the lung: a clinicopathologic review. Am J Clin Pathol. 1997;108:40–53
  11. Ro JY, Chen JL, Lee JS, Sahin AA, Ordonez NG, Ayala AG. Sarcomatoid carcinoma of the lung (Immunohistochemical and ultrastructural studies of 14 cases). Cancer. 1992;69:376–386
  12. Ishida T, Tateishi M, Kaneko S, Yano T, Mitsudomi T, Sugimachi K, et al. Carcinosarcoma and spindle cell carcinoma of the lung: clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg. 1990;100:844–852
  13. Fishback NF, Travis WD, Moran CA, Guinee DG, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. Cancer. 1994;73:2936–2945
  14. Raveglia F, Mezzetti M, Panigalli T, Furia S, Giuliani L, Conforti S, et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg. 2004;78:1742–1747
  15. Ginsberg SS, Buzaid AC, Stern H, Carter D. Giant cell carcinoma of the lung. Cancer. 1992;70:606–610
  16. Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer. 2001;34:91–97
  17. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–1717
  18. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995;75:191–202
  19. Kim TS, Han J, Lee KS, Jeong YJ, Kwak SH, Byun HS, et al. CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients. AJR Am J Roentgenol. 2005;185:120–125
  20. Kim TH, Kim SJ, Ryu YH, Lee HJ, Goo JM, Im JG, et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings. Radiology. 2004;232:554–559
  21. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg. 2005;130:151–159
  22. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg. 2001;71:1759–1764

PII: S0022-5223(07)00929-4

doi: 10.1016/j.jtcvs.2007.05.031

The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 3 , Pages 619-623 , September 2007

Article Tools

* Image Usage & Resolution